ICE Pharma is a Manufacturer/Innovator company operating in the pharmaceutical industry.
ICE Pharma is a niche API and speciality ingredients company focused on the development and manufacture of bile acid derivatives. ICE is one of the world’s main producers of Ursodeoxycholic Acid (UDCA). ICE Pharma has an integrated global manufacturing network in Europe, Latin America, Asia and Oceania that serves customers in over 50 countries. ICE Pharma’s five R&D centres have enabled it to develop a unique and comprehensive range of bile acid products including generic APIs, excipients, and new chemical entities.
Company type
Manufacturer/Innovator
Products and services
Excipients, Intermediates, Fine and Specialty Chemicals, Finished Dosage Forms, Natural Extracts, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with ICE Pharma on Facebook
Connect with ICE Pharma on LinkedIn
Address
ICE Pharma, Via Sicillia 8/10, Reggio Emilla, Italy, 42122
